Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari
HSE National Clinical Guideline

HSE National Clinical Guideline for the Management of Paediatric Type 1 Diabetes Patient who did not attend (DNA), were not brought or repeatedly cancels their appointments


Topic: Management of paediatric type 1 diabetes patient who did not attend (dna), were not brought or repeatedly cancels appointments
Document Owner: National Clinical Lead for Paediatric Diabetes
National Group: National Clinical Programme for Paediatrics and Neonatology Paediatric Diabetes Working Group
Effective From: 09 October 2025
The aim of this guideline is to provide clear and standardised guidelines for all staff caring for (and advising care givers of) children and young people who did not attend, were not brought or repeatedly cancel their appointments.
HSE National Clinical Guideline for the Management of Paediatric Type 1 Diabetes Patient who did not attend (DNA), were not brought or repeatedly cancels their appointments
PDF, 0.95MB

The purpose of this guideline is to provide a framework to improve the management of Paediatric Type 1 patients who did not attend, were not brought or repeatedly cancel their appointments through the implementa-tion of a consistent plan of care.

Back to HSE National Central Repository